West Nile Virus

News

Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial

Published December 2, 2008, 5:00 am, CNW Group via Yahoo! Finance

Response Biomedical Corporation announced the initiation of a clinical trial of the Company's RAMP test to detect Respiratory Syncytial Virus . Prospective data from the clinical study is expected to be used to support a submission to the U.S.

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery


Related West Nile Virus Stories

From Various News Sources

Response Biomedical Corporation Announces Initiation of Respiratory ... - Earthtimes
Author : Response Biomedical Corp. VANCOUVER , Dec. 2 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced the initiation of a clinical trial of the Company's RAMP(R) test to detect Respiratory Syncytial Virus ...

Related Social Bookmarks

None found at this time.


News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a